Published Healthcare & Pharmaceuticals Modulators of Class IIa HDACs UQ has exploited structural differences between Class I and IIa HDACs to develop two generations of new compounds that are potent and selective inhibitors of class IIa HDACs. By The University of Queensland
Published Healthcare & Pharmaceuticals C3a Receptor Modulators University of Queensland researchers have developed series of novel, potent and selective, small organic molecules that mimic C3a (agonists) or inhibit its action (antagonists) By The University of Queensland